This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Wiedermann, C. J. Articles by Willeit, J. Search for Related Content PubMed PubMed Citation Articles by Wiedermann, C. J. Articles by Willeit, J. Social Bookmarking                   What's this?

The role of immune activation in endotoxin-induced atherogenesis

Department of Internal Medicine, Faculty of Medicine, University of Innsbruck, Innsbruck, Austria, christian.wiedermann{at}uibk.ac.at

Stefan Kiechl

Department of Neurology, Faculty of Medicine, University of Innsbruck, Innsbruck, Austria

Peter Schratzberger

Department of Internal Medicine, Faculty of Medicine, University of Innsbruck, Innsbruck, Austria

Stefan Dunzendorfer

Department of Internal Medicine, Faculty of Medicine, University of Innsbruck, Innsbruck, Austria

Günther Weiss

Department of Internal Medicine, Faculty of Medicine, University of Innsbruck, Innsbruck, Austria

Johann Willeit

Department of Neurology, Faculty of Medicine, University of Innsbruck, Innsbruck, Austria

Some infectious agents may contribute to atherosclerosis by maintaining a heightened state of inflammatory response. Although the risk for atherosclerosis was associated with elevated plasma levels of endotoxin, it is difficult to firmly establish what place endotoxin assumes in the etiology of this disease. As the ability for endotoxin to promote disease may depend on its ability to initiate an inflammatory response, it may be controlled by additional regulatory factors. We measured plasma levels of endotoxin and serum levels of neopterin and soluble interleukin-2 receptor in a random population of 402 men and women, 50—79 years old at the 1990 baseline evaluation (Bruneck Study). End point of the prospective survey was incident (early) atherosclerosis in the carotid arteries as assessed with duplex ultrasound. Subjects with high endotoxin levels (90th percentile) in combination with low neopterin or soluble interleukin-2 receptor levels (below median) did not differ from those with low endotoxin in their risk of incident atherosclerosis. The risk associated with high endotoxin, however, was markedly elevated in subjects with high (above median) neopterin or soluble interleukin-2 receptor levels. The study provides epidemiological evidence that the atherogenic potential of endotoxemia is affected by concomitant immune activation.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?